On or before September 1, the Centers for Medicare and Medicaid Services will release the names of the 10 Part D drugs subject to negotiated prices in Medicare starting in 2026.
Industry awaits names of 10 drugs subject to federal price negotiation
On or before September 1, the Centers for Medicare and Medicaid Services will release the names of the 10 Part D drugs subject to negotiated prices in Medicare starting in 2026.